Our in-vitro results confirm functionality of certain miRNAs toward regulation of 3′-UTR via CFIm25 in breast cancer cells, which then introduce it as an emerging field of study in pre-clinical studies of breast cancer. This evidence concerns the gene NUDT21 and breast carcinoma.